Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement [1]

Heart

Volumn 85, Issue 1, 2001, Pages 92-93

  Muller I ^a   Seyfarth, M ^a   Rudiger S ^a   Wolf, B ^a   Pogatsa Murray, G ^a   Schomig A ^a   Gawaz, M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANTICOAGULANT AGENT; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; PADGEM PROTEIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE; TICLOPIDINE;

ANTICOAGULATION; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; DEGRANULATION; DOSE CALCULATION; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; FIBRINOLYTIC THERAPY; HUMAN; LETTER; LOADING TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION; THROMBOSIS; TREATMENT OUTCOME;

ASPIRIN; CORONARY DISEASE; CORONARY THROMBOSIS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HUMANS; PLATELET ACTIVATION; PLATELET AGGREGATION; STENTS; TICLOPIDINE;

EID: 0034762075     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents
2. A randomized, blinded trial of clopidogrel versus aspirin in patients at risk for ischemic events (CAPRIE)
3. Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement
4. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: The clopidogrel aspirin stent international cooperative study (CLASSICS)
5. Clopidogrel as adjunctive antiplatelet therapy during coronary stenting